← Evidence map

ArticleFEBS open bio2022

Development of a fully human anti-GITR antibody with potent antitumor activity using H2L2 mice.

Qiuli Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35674216